ALB and renal carcinoma: The measurement of the systemic inflammatory response has been subsequently refined using a selective combination of C-reactive protein and albumin (termed the modified Glasgow Prognostic Score, mGPS) and has been shown to have prognostic value, independent of tumour stage, in lung, gastrointestinal and renal cancers (McMillan, 2008, 2009).